Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435507
Status:
COMPLETED
Last Update Posted:
2024-07-05
First Post:
2024-05-20
Brief Title:
Phase I Clinical Trial to Evaluate the Safety Tolerability and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers
Sponsor:
Innovative Molecules GmbH
Organization:
Innovative Molecules GmbH
Organization Data
Organization:
Innovative Molecules GmbH
Class:
INDUSTRY
Study ID:
IM-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Innovative Molecules GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None